Study of Zevalin Versus Observation in Participants at Least 60 Years Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in Positron Emission Tomography (PET)-Negative Complete Remission After Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) or R-CHOP-like Therapy
Public ClinicalTrials.gov record NCT01510184. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Open-label, Multicenter, Randomized Study of Sequential Zevalin (Ibritumomab Tiuxetan) Versus Observation in Patients at Least 60 Years of Age With Newly Diagnosed Diffuse Large B-cell Lymphoma in PET-negative Complete Remission After R-CHOP or R-CHOP-like Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of Zevalin compared with observation alone in participants who are in PET-negative complete remission after first-line R-CHOP or R-CHOP like therapy.
Study identification
- NCT ID
- NCT01510184
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 79 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 60 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 19, 2012 (Actual)
- Primary completion
- Oct 23, 2014 (Actual)
- Completion
- Oct 23, 2014 (Actual)
- Last update posted
- Dec 16, 2021
2012 – 2014
United States locations
- U.S. sites
- 28
- U.S. states
- 21
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cancer Treatment Services Arizona | Casa Grande | Arizona | 85122 | — |
| Sutter East Bay Hospitals | Berkeley | California | 94704 | — |
| City of Hope | Duarte | California | 91010 | — |
| Halifax Health Medical Center | Daytona Beach | Florida | 32114 | — |
| H. Lee Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Piedmont Hospital Cancer Center | Atlanta | Georgia | 30318 | — |
| St. Luke's Mountain States Tumor Institute (MSTI) | Boise | Idaho | 83712 | — |
| Northwestern University Feinberg School of Medicine | Chicago | Illinois | 60611 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Decatur Memorial Hospital Cancer Care Specialists of Central Illinois | Decatur | Illinois | 62526 | — |
| Illinois Cancer Specialists | Niles | Illinois | 60714 | — |
| Midwestern Regional Medical Center | Zion | Illinois | 60099 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| Norton Cancer Institute, Suburban | Louisville | Kentucky | 40207 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| St. John Hospital and Medical Center | Grosse Pointe Woods | Michigan | 48236 | — |
| Oncology Research-Park Nicollet Institute | Saint Louis Park | Minnesota | 55426 | — |
| Saint Louis University | St Louis | Missouri | 63110 | — |
| Comprehensive Cancer Centers of Nevada | Henderson | Nevada | 89044 | — |
| Hackensack UMC / John Theurer Cancer Center | Hackensack | New Jersey | 07601 | — |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | — |
| Adams Cancer center | Gettysburg | Pennsylvania | 17325 | — |
| York Cancer Center / Cancer Care Associates of York | York | Pennsylvania | 17403 | — |
| Saint Francis Hospital | Greenville | South Carolina | 29601 | — |
| Avera Hematology and Transplant | Sioux Falls | South Dakota | 57105 | — |
| Associates In Oncology and Hematology | Chattanooga | Tennessee | 37421 | — |
| The University of Texas M.D. Anderson Cancer Center | Houston | Texas | 77030 | — |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01510184, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2021 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01510184 live on ClinicalTrials.gov.